# Animab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/animab

- Industry: Biotechnology
- Headquarters: Gent, Belgium
- Website: www.animab.com/
- Total disclosed funding: $25M
- Latest round: Series B (Jul 1, 2025)
- Investors on record: 8

## About

Based in the Flemish Region, Belgium, and founded in 2020 by scientific co-founders Vikram Virdi (Scientific Director), Ann Depicker, Nico Callewaert, Eric Cox, and Henri De Greve, Animab BV operates as a biotechnology company offering technology for generating monoclonal antibodies to livestock.

## Funding rounds

- Series B, Jul 1, 2025, $12M — Seventure Partners, Baekeland Fonds, PMV, VIB, Agri Investment Fund, Qbic Fund, V-Bio Ventures, Anacura
- Series A, May 29, 2024, $4.6M — PMV, Agri Investment Fund, Qbic Fund
- Series A, Nov 3, 2022, $5M — PMV, Agri Investment Fund, Qbic Fund
- Seed, Oct 21, 2020, $4M — Seventure Partners, PMV, VIB, Agri Investment Fund, V-Bio Ventures

## Investors

- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Seed, Series B
- PMV (https://capitalatlas.ai/funds/pmv) — Seed, Series A, Series B
- VIB — Seed, Series B
- Agri Investment Fund (https://capitalatlas.ai/funds/agri-investment-fund) — Seed, Series A, Series B
- V-Bio Ventures (https://capitalatlas.ai/funds/v-bio-ventures) — Seed, Series B
- Qbic Fund (https://capitalatlas.ai/funds/qbic-fund) — Series A, Series B
- Baekeland Fonds (https://capitalatlas.ai/funds/baekeland-fonds) — Series B
- Anacura — Series B